Federal Specific Company (FedEx), one of many world’s largest categorical transportation corporations, has expanded its state-of-the-art Life Science Heart in Gimpo, Gyeonggi-do, Korea. This strategic enhancement, together with FedEx Life Science Facilities in Singapore and Japan, is addressing the rising demand for a strong logistics community with superior capabilities to assist the quickly rising healthcare business throughout the Asia Pacific area.
The superior FedEx Korea Life Science Heart spans 2,288 sq. meters – virtually triple the dimensions of the earlier facility. The brand new operation consists of 5 temperature-controlled areas for temperatures starting from -150°C to +25°C, that are monitored 24/7 to make sure steady compliance with pharmaceutical chilly chain necessities. The power can be Korea Good Provide Apply (KGSP)-certified, in accordance with market-specific high quality and regulatory necessities for the healthcare business. Together with temperature-controlled Stock administration capabilities, the Korea Life Science Heart is supplied to assist each home and worldwide transportation wants.
By increasing its capability, FedEx is strengthening its life sciences logistics experience, making certain seamless and dependable transportation of important healthcare shipments together with investigational medicinal merchandise (IMP), organic samples, and biopharmaceutical product strains whereas enabling pharmaceutical and scientific trials clients to prioritize affected person care.
The pharmaceutical market in Asia Pacific is projected to succeed in USD 290 billion by 2028. Moreover, the area accounts for roughly 50% of world scientific trials, highlighting its growing function in international pharmaceutical analysis and improvement. Clients within the healthcare and pharmaceutical sector want exact, temperature-controlled providers to protect product efficacy. With a long time of expertise, FedEx offers experience in specialised healthcare and scientific trial options, enabled by its worldwide Specific community, custom-made Time Essential Particular Providers (SpS), and a world community of Life Science Facilities with areas in Korea, Singapore, Tokyo (Japan), Mumbai (India), Memphis (United States), and Veldhoven (the Netherlands). The corporate’s intensive healthcare infrastructure additionally consists of 130+ cold-chain services worldwide, making certain steady temperature integrity for shipments shifting by means of our home and worldwide networks.
“Asia Pacific’s healthcare sector is evolving at an unprecedented tempo, pushed by demographic shifts, infrastructure investments, and fast tech developments,” stated Kawal Preet, president, Asia Pacific at FedEx. “At FedEx, we’re leveraging our a long time of healthcare experience, intensive international community and differentiated options to propel this progress. By strategic investments in cutting-edge services and AI-driven sensible logistics, we’re reshaping healthcare provide chains and enabling the way forward for life sciences analysis and enterprise innovation throughout the area.”
FedEx Medical Care, a part of the corporate’s portfolio of devoted healthcare transportation options, offers end-to-end supply capabilities for time and temperature-sensitive healthcare shipments. This service ensures expedited supply inside 24 to 48 hours, leveraging specialised options together with temperature-controlled packaging, precedence dealing with and clearance, and 24/7 monitoring and intervention utilizing sensor-based real-time monitoring.
Just lately, FedEx was acknowledged for ‘Innovation in Medical Provide Chain Logistics’ on the Korea Biopharma Excellence Awards 2024 for distinctive contribution to scientific provide chains in Korea. In August, the corporate launched FedEx Encompass®, an revolutionary monitoring and intervention answer for enhanced management and visibility for healthcare and different important shipments.
